Current status date:
2018-08-31
Description:
INITIATION PACK
DIN:
02479230
Electronic product monograph is not available
Company:
TAKEDA CANADA INC
3800
22 Adelaide Street West
Toronto
Ontario
Canada
M5H 4E3
Dosage form(s):
Tablet
,
Kit
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
Prescription
Anatomical Therapeutic Chemical (ATC):
See footnote 4
L01ED04 BRIGATINIB
List of active ingredient(s)
Active ingredient(s) |
Strength |
BRIGATINIB
|
180 MG
|
BRIGATINIB
|
90 MG
|
A Risk Management Plan (RMP) for this product was submitted.